Company Overview of MacroArray Technology, LLC
MacroArray Technology, LLC, a biotechnology research company, develops DNA array technologies and novel proteomics based platforms to identify marker genes that are critical to cancer cell growth and survival. It focuses in the area of prostate cancer. The company offers PCADM-1 urine-based diagnostic marker to replace the PSA test. It also offers proteomics platform for novel marker discovery; DNA-protein binding technology; methods for cloning/identification of genes/proteins; immunoassays for tissue/fluid markers; linking diagnostic markers; and DNA ZYM therapeutic agents for the treatment of cancer. MacroArray Technology, LLC is based in Villanova, Pennsylvania.
503 Chaumont Drive
Villanova, PA 19085
Key Executives for MacroArray Technology, LLC
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact MacroArray Technology, LLC, please visit www.macroarraytechnologies.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.